354 related articles for article (PubMed ID: 26805715)
1. Update on molecular mechanisms of corticosteroid resistance in chronic obstructive pulmonary disease.
Jiang Z; Zhu L
Pulm Pharmacol Ther; 2016 Apr; 37():1-8. PubMed ID: 26805715
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids: the drugs to beat.
Barnes PJ
Eur J Pharmacol; 2006 Mar; 533(1-3):2-14. PubMed ID: 16436275
[TBL] [Abstract][Full Text] [Related]
3. Denitrosylation of HDAC2 by targeting Nrf2 restores glucocorticosteroid sensitivity in macrophages from COPD patients.
Malhotra D; Thimmulappa RK; Mercado N; Ito K; Kombairaju P; Kumar S; Ma J; Feller-Kopman D; Wise R; Barnes P; Biswal S
J Clin Invest; 2011 Nov; 121(11):4289-302. PubMed ID: 22005302
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction.
Hakim A; Adcock IM; Usmani OS
Drugs; 2012 Jul; 72(10):1299-312. PubMed ID: 22731962
[TBL] [Abstract][Full Text] [Related]
5. Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model.
Gan L; Li C; Wang J; Guo X
Int J Chron Obstruct Pulmon Dis; 2016; 11():2765-2773. PubMed ID: 27853364
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.
Barnes PJ; Ito K; Adcock IM
Lancet; 2004 Feb; 363(9410):731-3. PubMed ID: 15001333
[TBL] [Abstract][Full Text] [Related]
7. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
Tamimi A; Serdarevic D; Hanania NA
Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
[TBL] [Abstract][Full Text] [Related]
8. Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients.
Milara J; Cervera A; de Diego A; Sanz C; Juan G; Gavaldà A; Miralpeix M; Morcillo E; Cortijo J
Respir Res; 2016 Nov; 17(1):145. PubMed ID: 27825347
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease.
Barnes PJ
J Allergy Clin Immunol; 2013 Mar; 131(3):636-45. PubMed ID: 23360759
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD.
Mei D; Tan WSD; Wong WSF
Curr Opin Pharmacol; 2019 Jun; 46():73-81. PubMed ID: 31078066
[TBL] [Abstract][Full Text] [Related]
11. Restoration of Corticosteroid Sensitivity in Chronic Obstructive Pulmonary Disease by Inhibition of Mammalian Target of Rapamycin.
Mitani A; Ito K; Vuppusetty C; Barnes PJ; Mercado N
Am J Respir Crit Care Med; 2016 Jan; 193(2):143-53. PubMed ID: 26426522
[TBL] [Abstract][Full Text] [Related]
12. Development of new drugs for COPD.
Barnes PJ
Curr Med Chem; 2013; 20(12):1531-40. PubMed ID: 22963554
[TBL] [Abstract][Full Text] [Related]
13. Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression.
Sun XJ; Li ZH; Zhang Y; Zhou G; Zhang JQ; Deng JM; Bai J; Liu GN; Li MH; MacNee W; Zhong XN; He ZY
Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L139-46. PubMed ID: 25957293
[TBL] [Abstract][Full Text] [Related]
14. MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease.
Milara J; Díaz-Platas L; Contreras S; Ribera P; Roger I; Ballester B; Montero P; Cogolludo Á; Morcillo E; Cortijo J
Respir Res; 2018 Nov; 19(1):226. PubMed ID: 30458870
[TBL] [Abstract][Full Text] [Related]
15. New insights into the molecular mechanisms of corticosteroids actions.
Adcock IM; Caramori G; Ito K
Curr Drug Targets; 2006 Jun; 7(6):649-60. PubMed ID: 16787166
[TBL] [Abstract][Full Text] [Related]
16. Steroid resistance in COPD is associated with impaired molecular chaperone Hsp90 expression by pro-inflammatory lymphocytes.
Hodge G; Roscioli E; Jersmann H; Tran HB; Holmes M; Reynolds PN; Hodge S
Respir Res; 2016 Oct; 17(1):135. PubMed ID: 27769261
[TBL] [Abstract][Full Text] [Related]
17. Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy.
Hakim A; Usmani OS
Ther Deliv; 2015; 6(4):443-51. PubMed ID: 25996043
[TBL] [Abstract][Full Text] [Related]
18. Theophylline in chronic obstructive pulmonary disease: new horizons.
Barnes PJ
Proc Am Thorac Soc; 2005; 2(4):334-9; discussion 340-1. PubMed ID: 16267358
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
